Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
JYNT 
The Joint Corp (JYNT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: JYNT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $15.38
1 Year Target Price $15.38
| 2 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -33.27% | Avg. Invested days 29 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 174.76M USD | Price to earnings Ratio - | 1Y Target Price 15.38 |
Price to earnings Ratio - | 1Y Target Price 15.38 | ||
Volume (30-day avg) 5 | Beta 1.49 | 52 Weeks Range 9.58 - 15.31 | Updated Date 06/30/2025 |
52 Weeks Range 9.58 - 15.31 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.1 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -16.43% | Operating Margin (TTM) -5.17% |
Management Effectiveness
Return on Assets (TTM) -1.06% | Return on Equity (TTM) -7.13% |
Valuation
Trailing PE - | Forward PE 32.57 | Enterprise Value 154937047 | Price to Sales(TTM) 3.31 |
Enterprise Value 154937047 | Price to Sales(TTM) 3.31 | ||
Enterprise Value to Revenue 2.94 | Enterprise Value to EBITDA 90.3 | Shares Outstanding 15302800 | Shares Floating 10016888 |
Shares Outstanding 15302800 | Shares Floating 10016888 | ||
Percent Insiders 8.81 | Percent Institutions 74.39 |
Analyst Ratings
Rating 3 | Target Price 15.38 | Buy 1 | Strong Buy 2 |
Buy 1 | Strong Buy 2 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
The Joint Corp
Company Overview
History and Background
The Joint Corp. was founded in 1999 and began franchising in 2003. It provides access to chiropractic care through a membership-based model. The company has expanded through franchising and corporate-owned clinics.
Core Business Areas
- Franchising: The Joint Corp franchises chiropractic clinics, providing franchisees with a business model, brand recognition, and support system. Revenue is derived from franchise fees and royalties.
- Company-Owned Clinics: The company operates clinics to generate direct revenue and to provide pilot locations for best practices.
Leadership and Structure
Peter Holt is the President and CEO. The organizational structure consists of corporate leadership and operational teams for both franchising and company-owned clinics.
Top Products and Market Share
Key Offerings
- Chiropractic Services: Affordable and accessible chiropractic adjustments are provided on a walk-in basis through a membership model. The revenue is mainly from membership fees. Competitors include individual chiropractic practices and other franchised chiropractic groups. Market share is estimated to be around 25% of the franchised chiropractic market.
- Retail Products: The Joint offers some related retail products, such as supplements, but these are a minor revenue stream. Competitors include general health and wellness product retailers.
Market Dynamics
Industry Overview
The chiropractic care industry is fragmented, consisting of independent practices and franchised chains. Demand is driven by an aging population, increased awareness of alternative medicine, and rising healthcare costs.
Positioning
The Joint Corp. positions itself as a convenient and affordable alternative to traditional chiropractic care, appealing to a broader customer base. It differentiates itself through its membership model and walk-in service.
Total Addressable Market (TAM)
The estimated total addressable market (TAM) for chiropractic services in the US is around $16 billion. The Joint Corp is positioned to capture a growing share of this market through expansion and increased brand awareness.
Upturn SWOT Analysis
Strengths
- Franchise model allows for rapid expansion
- Membership-based revenue provides recurring income
- Affordable pricing appeals to a wider customer base
- Convenient walk-in service
- Strong brand recognition
Weaknesses
- Reliance on franchisees for quality control
- Potential for negative brand impact from franchisee issues
- Limited service offerings compared to traditional chiropractic practices
- Geographic concentration in certain regions
Opportunities
- Expanding into new geographic markets
- Increasing brand awareness through marketing
- Developing partnerships with insurance providers
- Introducing new service offerings
- Growth in holistic medicine and wellness trends
Threats
- Competition from individual chiropractic practices
- Changes in healthcare regulations
- Economic downturn impacting consumer spending
- Increased competition from other franchised chiropractic chains
- Negative publicity related to chiropractic care
Competitors and Market Share
Key Competitors
- NUVA
- DOCS
Competitive Landscape
The Joint Corp. has a competitive advantage in its affordable pricing and convenient service. However, it faces competition from individual chiropractic practices and other franchised chains with more comprehensive service offerings.
Growth Trajectory and Initiatives
Historical Growth: The Joint Corp. has experienced rapid growth in the number of clinics and revenue over the past five years.
Future Projections: Analysts project continued revenue growth of around 15-20% per year, driven by new clinic openings and same-store sales growth.
Recent Initiatives: Recent initiatives include expanding the franchise network, investing in marketing and technology, and improving franchisee support.
Summary
The Joint Corp. is a growing company with a strong franchise model and a focus on accessible chiropractic care. Its strengths lie in its affordability and convenience, while weaknesses include reliance on franchisees. The company is positioned to capitalize on the growing demand for alternative healthcare, but needs to be mindful of competition and regulatory changes.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Analyst Reports
- Industry Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share estimates are approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About The Joint Corp
Exchange NASDAQ | Headquaters Scottsdale, AZ, United States | ||
IPO Launch date 2014-11-11 | CEO, President & Director Mr. Sanjiv Razdan | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 443 | Website https://www.thejoint.com |
Full time employees 443 | Website https://www.thejoint.com | ||
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.